HIGHLIGHTS
- who: Ashwini Shete1 and Madhuri Thakar1 from the National Research Institute, Indian Council of Medical Research, G block, MIDC, Bhosari, Pune-411026, India have published the Article: Is Prime Boost Strategy A Promising Approach in HIV Vaccine Development?, in the Journal: (JOURNAL)
- what: The available evidence suggests that the heterologous prime-boost vaccination approach has some promise in HIV vaccine development.
- how: RV144 trial data showed that high level of ADCC activity was inversely correlated with infection risk.
- future: It is important that the future trials should assess immune_responses generated at . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.